Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 35

Many initiatives and organizations with interest in broader adoption of biosimilars have come into being, driven by governments and/or private organizations and agencies including patient advocacy groups. A summary of these is provided as these initiatives and organizations affect the information flow and influence the uptake of innovator biologics and biosimilars. The intent here is not to discuss comprehensively every national or international initiative on the adoption of biosimilars but to present some prominent exemplars so that the reader is able to map to similar national and local initiative(s) in their own country. If such initiatives are not currently available in a country, then the reader may also be able to facilitate the creation of such an initiative tailored to the specific needs of their country.